By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Important Data Ahead Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows that Nasdaq 100 has pulled back after touching the low band of the resistance zone.
By Nigam Arora & Dr. Natasha Arora Intelligence to prepare you in advance to act advantageously when a signal to act arrives. Lucrative Opportunities Lucrative opportunities are ahead in personalized cancer vaccines. Several ideas are on our radar at The Arora Report. Cancer Vaccines Are Different A cancer vaccine is
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Pay Attention To Putin On Taiwan If you are holding stocks such as Apple (AAPL), Tesla (TSLA), Starbucks (SBUX), Blackrock (BLK), Nike (NKE), and Nvidia (NVDA) or if you are holding
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora Being able to sell stocks correctly is as important as buying stocks correctly. Most services and analysts get investors into stocks but do not get them out in a timely manner. The Arora Report is the only reputable service of its kind
By Nigam Arora & Dr. Natasha Arora Game Changer Merck (MRK) has announced that its oral antiviral pill molnupiravir reduces the death risk from COVID by 50%. 7.3% of those who received the pill were either hospitalized or died through Day 29 compared with 14.1% of those who received the
New developments in clinical trials and drug approvals have become commonplace. And buyouts of biotech stocks at high premiums are increasing. Here is how to get your share of the outsized gains that are being generated. Let’s explore the issue with the help of two charts. Please click here for an annotated
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
The House of Representatives has started an impeachment inquiry into President Trump. What does that mean for investors? First and foremost, I am politically agnostic. My sole job is to help investors achieve high risk-adjusted returns. This column is neither about politics nor about the merits of the impeachment inquiry.